Vontobel Holding Ltd. increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 31.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 67,519 shares of the company's stock after purchasing an additional 16,125 shares during the quarter. Vontobel Holding Ltd.'s holdings in Cardinal Health were worth $7,985,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. State Street Corp grew its holdings in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock valued at $1,566,913,000 after buying an additional 627,253 shares during the period. Two Sigma Advisers LP lifted its stake in shares of Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock valued at $118,197,000 after purchasing an additional 346,362 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Cardinal Health by 230.0% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock valued at $52,819,000 after purchasing an additional 333,095 shares in the last quarter. Worldquant Millennium Advisors LLC lifted its stake in shares of Cardinal Health by 77.3% in the 3rd quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company's stock valued at $65,539,000 after purchasing an additional 258,541 shares in the last quarter. Finally, Pacer Advisors Inc. lifted its stake in shares of Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company's stock valued at $474,203,000 after purchasing an additional 191,568 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on CAH shares. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price objective on the stock in a research note on Tuesday, January 7th. UBS Group boosted their price target on Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. Wells Fargo & Company boosted their price target on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Finally, Morgan Stanley boosted their price target on Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research report on Friday, January 31st. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $136.87.
View Our Latest Stock Report on CAH
Cardinal Health Stock Performance
Shares of NYSE CAH traded up $0.38 during trading on Wednesday, reaching $126.63. The stock had a trading volume of 2,244,532 shares, compared to its average volume of 2,350,062. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $132.84. The stock has a market cap of $30.59 billion, a PE ratio of 23.63, a P/E/G ratio of 1.48 and a beta of 0.63. The firm's 50 day moving average price is $123.06 and its two-hundred day moving average price is $116.74.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.60%. Cardinal Health's dividend payout ratio (DPR) is 37.69%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
